The effect of the newly developed, nonpeptide, calpain inhibitor, PD 1
50606, on hypoxia and ionomycin-induced increases in calpain activity
in rat proximal tubules (PT) was determined. PD150606 inhibited both h
ypoxia and ionomycin-induced calpain activity as determinrd by the flu
orescent substrate N-succinyl-Leu-Leu-Val-Tyr-7-amido-4-methyl coumari
n (N-succinyl-Leu-Leu-Val-Tyr-AMC). This decrease in calpain activity
was accompanied by dose-dependent cytoprotection against hypoxia and i
onomycin-induced cell membrane damage. PD150606 had no effect on cathe
psin B and L activity in PT as measured by the fluorescent substrate,
-phenylalanyl-L-arginine-7-amido-4-methyl-coumarin (Z-Phe-Arg-AMC). Th
e effects of low intracellular pH (pH(i)) or low free cytosolic calciu
m [Ca2+](i) on this hypoxia-induced calpain activity were also determi
ned. Both low pH(i) and low [Ca2+](i) attenuated the hypoxia-induced i
ncrease in calpain activity. This attenuation of calpain activity was
observed early before hypoxia-induced membrane damage and was associat
ed with marked reduction in the typical pattern of hypoxia-induced cel
l membrane damage observed in this model. To identify the isoform of c
alpain activated in rat proximal tubules, normoxic. hypoxic and ionomy
cin treated tubules were fractionated by MONO-Q anion exchange chromat
ography and the fractions were assayed for calpain activity. A single
peak of calpain activity characteristic of mu-calpain was found. The c
alcium dependency of the calpain activity was in the nanomolar range,
further confirming that the activity was the low Ca2+-sensitive mu-cal
pain. The present study suggest that in rat proximal tubules: (1) PD 1
50606 is a specific inhibitor of calpain and not cathepsins B and L; (
2) the cytoprotective effects of low pH(i) and low [Ca2+](i) are media
ted, at least in part, by inhibition of calpain activity; and (3) the
predominant active form of calpain is the isoenzyme mu-calpain.